
ImprimisRx, a San Diego-based specialty pharmaceutical company, develops and commercializes novel, customizable medicines at accessible prices.
ImprimisRx, founded in San Diego, California, is a specialty pharmaceutical company dedicated to developing and commercializing proprietary and novel sterile and topical drug formulations. The company's core mission is to deliver customizable medicines to physicians and patients at accessible prices. ImprimisRx operates an FDA-Registered 503B Outsourcing Facility, ensuring high-quality production standards. Their market focus includes providing innovative solutions in the pharmaceutical sector, particularly for those requiring specialized and tailored medications.
Notable affiliated individuals include a team of experienced pharmaceutical professionals committed to advancing the company's mission. ImprimisRx has garnered attention for its unique business model and rapid growth in the industry. Key achievements include the successful commercialization of several novel drug formulations, enhancing patient care through accessible medication options. The overall impact of ImprimisRx is significant, as it addresses the need for customizable and affordable pharmaceutical solutions, thereby improving healthcare outcomes for a broad range of patients.
Companies similar to ImprimisRx include US Specialty Formulations, Pinpoint Pharma, Amphastar Pharmaceuticals and ImpriMed.
ImprimisRx was founded in 1995.
ImprimisRx's headquarters is located in Carlsbad, CA, US.
ImprimisRx's most recent funding round was for $253k (USD) in December 2022.
As of Dec 20, 2022, ImprimisRx has raised a total of $253k (USD).
ImprimisRx has 123 employees as of Feb 4, 2024.
Amphastar Pharmaceuticals
amphastar.com